<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37027203</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2369-2960</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><PubDate><Year>2023</Year><Month>Apr</Month><Day>07</Day></PubDate></JournalIssue><Title>JMIR public health and surveillance</Title><ISOAbbreviation>JMIR Public Health Surveill</ISOAbbreviation></Journal><ArticleTitle>Health Care-Seeking Behaviors, Disease Progression, Medications, Knowledge of, and Attitudes Toward Systemic Lupus Erythematosus in China: Cross-sectional Survey Study.</ArticleTitle><Pagination><StartPage>e44541</StartPage><MedlinePgn>e44541</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e44541</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/44541</ELocationID><Abstract><AbstractText Label="BACKGROUND">Systemic lupus erythematosus (SLE) is a systemic autoimmune disease involving multiple organs throughout the body. The health care-seeking behaviors, disease progression of SLE, and patients' knowledge of and attitudes toward SLE have not been characterized in China.</AbstractText><AbstractText Label="OBJECTIVE">The aim of this study was to depict the health care-seeking behaviors, disease progression, and medications in patients with SLE and to examine the factors associated with their disease flares, knowledge, and attitudes toward SLE in China.</AbstractText><AbstractText Label="METHODS">We conducted a cross-sectional survey in 27 provinces in China. Descriptive statistical methods were used to depict the demographic characteristics, health care-seeking behaviors, medications, and health status. Multivariable logistic regression models were used to identify the factors associated with disease flares, medication changes, and attitudes toward SLE. An ordinal regression model was used to examine the factors associated with the knowledge of the treatment guidelines.</AbstractText><AbstractText Label="RESULTS">We recruited 1509 patients with SLE, and 715 had lupus nephritis (LN). Approximately 39.96% (603/1509) of the patients with SLE were primarily diagnosed with LN, and 12.4% (112/906) developed LN (mean time 5.2 years) from non-LN. Patients whose registered permanent residences or workplaces in other cities from the same province and adjacent provinces seeking health care accounted for 66.9% (569/850) and 48.8% (479/981) of the patients with SLE in the provincial capital cities, respectively. Mycophenolate mofetil was the most commonly used immunosuppressive drug in patients without LN (185/794, 23.3%) and patients with LN (307/715, 42.9%). Femoral head necrosis (71/228, 31.1%) and hypertension (99/229, 43.2%) were the most common adverse event (AE) and chronic disease during treatment, respectively. Change of hospitals for medical consultation (odds ratio [OR] 1.90, 95% CI 1.24-2.90) and development of 1 chronic disease (OR 3.60, 95% CI 2.04-6.24) and AE (OR 2.06, 95% CI 1.46-2.92) and more were associated with disease flares. A pregnancy plan (OR 1.58, 95% CI 1.18-2.13) was associated with changes in medication. Only 242 (16.03%) patients with SLE were familiar with the treatment guidelines, and patients with LN tended to be more familiar with the disease (OR 2.20, 95% CI 1.81-2.68). After receiving treatment, 891 (59.04%) patients changed their attitudes toward SLE from fear to acceptance, and patients with college education or higher (OR 2.09, 95% CI 1.10-4.04) were associated with a positive attitude toward SLE.</AbstractText><AbstractText Label="CONCLUSIONS">A large proportion of patients seeking health care in the provincial capital cities of China migrated from other cities. Persistent monitoring of potential AEs and chronic diseases during SLE treatment and managing patients who changed hospitals for medical consultation are essential for controlling disease flares. Patients had insufficient knowledge about SLE treatment guidelines and would benefit from health education to maintain a positive attitude toward SLE.</AbstractText><CopyrightInformation>&#xa9;Zonglin Dai, Xinxiang Huang, Fei Yuan, Tianwang Li, Baozhao Xie, He Lin, Pingting Yang, Xueyi Li, Shuiming Xu, Jinjun Zhao, Yukai Wang, Xiang Peng, Simin Wei, Wei Huang, Jingyang Li, Jing Liang, Xiuhua Liu, Yongliang Chu, Zhiming Zhang, Renpeng Zhang, Eric H Y Lau, Zhiming Lin. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 07.04.2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Zonglin</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-0272-3248</Identifier><AffiliationInfo><Affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xinxiang</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-9154-5801</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Fei</ForeName><Initials>F</Initials><Identifier Source="ORCID">0009-0001-6975-9969</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, Dongguan People's Hospital, Dongguan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tianwang</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-6438-2691</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Guangdong Second Provincial General Hospital, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Baozhao</ForeName><Initials>B</Initials><Identifier Source="ORCID">0009-0007-8358-4783</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The Seventh Affiliated Hospital, Guangxi Medical University, Wuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>He</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-8030-8280</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Pingting</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-2800-7947</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital of China Medical University, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xueyi</ForeName><Initials>X</Initials><Identifier Source="ORCID">0009-0005-9727-7085</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Shuiming</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0006-9101-1099</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Ganzhou Municipal Hospital, Ganzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jinjun</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2664-1389</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yukai</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-2468-3208</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Shantou Central Hospital, Shantou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><Identifier Source="ORCID">0009-0006-1574-9016</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The Sixth Affiliated Hospital of Guangzhou Medical University (Qingyuan People's Hospital), Qingyuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Simin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0002-9975-6619</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Guigang People's Hospital, Guigang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0009-0008-9730-7872</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jingyang</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0003-0662-0091</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, The Affiliated Zhuzhou Hospital of Xiangya Medical College of Central South University, Zhuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Jing</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0004-6068-9732</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, Huadu Affiliated Hospital of Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiuhua</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-5511-8204</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Liuzhou Worker's Hospital, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Yongliang</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-1689-8006</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Guangdong Province Hospital of Traditional Chinese Medicine, Zhuhai Branch, Zhuhai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhiming</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0009-0004-7500-9007</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Renpeng</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7201-3551</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, The First People's Hospital of Zhaotong, Zhaotong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lau</LastName><ForeName>Eric H Y</ForeName><Initials>EHY</Initials><Identifier Source="ORCID">0000-0002-6688-9637</Identifier><AffiliationInfo><Affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Data Discovery for Health, Hong Kong Science Park, Hong Kong, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lin</LastName><ForeName>Zhiming</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-9341-4303</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Public Health Surveill</MedlineTA><NlmUniqueID>101669345</NlmUniqueID><ISSNLinking>2369-2960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">attitudes</Keyword><Keyword MajorTopicYN="N">disease progression</Keyword><Keyword MajorTopicYN="N">health care&#x2013;seeking behaviors</Keyword><Keyword MajorTopicYN="N">knowledge</Keyword><Keyword MajorTopicYN="N">medications</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>Conflicts of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The surveys of 7 older patients (age range 67-86 years) among the 1509 participants were filled out by their doctors because these patients could not operate the digital survey or understand the questions. The surveys were answered by doctors in the presence of these patients who also confirmed the responses. There was no conflict of interest for the doctors who assisted the 7 older patients.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>7</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37027203</ArticleId><ArticleId IdType="pmc">PMC10131714</ArticleId><ArticleId IdType="doi">10.2196/44541</ArticleId><ArticleId IdType="pii">v9i1e44541</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD. Manifestations of systemic lupus erythematosus. Maedica (Bucur) 2011 Oct;6(4):330&#x2013;6. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3391953</ArticleId><ArticleId IdType="pubmed">22879850</ArticleId></ArticleIdList></Reference><Reference><Citation>Tektonidou MG, Lewandowski LB, Hu J, Dasgupta A, Ward MM. Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis. 2017 Dec;76(12):2009&#x2013;2016. doi: 10.1136/annrheumdis-2017-211663.annrheumdis-2017-211663</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2017-211663</ArticleId><ArticleId IdType="pubmed">28794077</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, Luo K. Concentration of Healthcare Resources in China: The Spatial-Temporal Evolution and Its Spatial Drivers. Int J Environ Res Public Health. 2019 Nov 20;16:23. doi: 10.3390/ijerph16234606. 
 
ijerph16234606</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph16234606</ArticleId><ArticleId IdType="pmc">PMC6926674</ArticleId><ArticleId IdType="pubmed">31757034</ArticleId></ArticleIdList></Reference><Reference><Citation>Nong S, Chen Z. Whither the roads lead to? Estimating association between urbanization and primary healthcare service use with chinese prefecture-level data in 2014. PLoS One. 2020;15(6):e0234081. doi: 10.1371/journal.pone.0234081. 
 
PONE-D-20-00001</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0234081</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0234081</ArticleId><ArticleId IdType="pmc">PMC7269333</ArticleId><ArticleId IdType="pubmed">32492048</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilmola O, Henttu V. Transportation costs do matter: simulation study from hospital investment decision. JM2. 2016 May 09;11(2):560&#x2013;584. doi: 10.1108/jm2-10-2013-0053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/jm2-10-2013-0053</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014 Dec;20(4):327&#x2013;37. doi: 10.3350/cmh.2014.20.4.327. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3350/cmh.2014.20.4.327</ArticleId><ArticleId IdType="pmc">PMC4278062</ArticleId><ArticleId IdType="pubmed">25548737</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlavilla Ana, Guti&#xe9;rrez Eduardo, Ortu&#xf1;o Teresa, Morales Enrique, Gonz&#xe1;lez Ester, Praga Manuel. Relapse of lupus nephritis more than 10 years after complete remission. Nephrol Dial Transplant. 2005 Sep;20(9):1994&#x2013;8. doi: 10.1093/ndt/gfh954.gfh954</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfh954</ArticleId><ArticleId IdType="pubmed">15985510</ArticleId></ArticleIdList></Reference><Reference><Citation>El Hachmi M, Jadoul M, Lef&#xe8;bvre C, Depresseux G, Houssiau FA. Relapses of lupus nephritis: incidence, risk factors, serology and impact on outcome. Lupus. 2003;12(9):692&#x2013;6. doi: 10.1191/0961203303lu444oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203303lu444oa</ArticleId><ArticleId IdType="pubmed">14514132</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakati S, Teronpi R, Barman B. Frequency, pattern and determinants of flare in systemic lupus erythematosus: A study from North East India. The Egyptian Rheumatologist. 2015 Oct;37(4):S55&#x2013;S59. doi: 10.1016/j.ejr.2015.08.002. doi: 10.1016/j.ejr.2015.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejr.2015.08.002</ArticleId><ArticleId IdType="doi">10.1016/j.ejr.2015.08.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamichou C, Bertsias G. Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies. Mediterr J Rheumatol. 2017 Mar;28(1):4&#x2013;12. doi: 10.31138/mjr.28.1.4. 
 
MJR-28-1-4</Citation><ArticleIdList><ArticleId IdType="doi">10.31138/mjr.28.1.4</ArticleId><ArticleId IdType="pmc">PMC7045928</ArticleId><ArticleId IdType="pubmed">32185248</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards CJ, Lian TY, Badsha H, Teh CL, Arden N, Chng HH. Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome. Lupus. 2003;12(9):672&#x2013;6. doi: 10.1191/0961203303lu452oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203303lu452oa</ArticleId><ArticleId IdType="pubmed">14514129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugarte-Gil MF, Acevedo-V&#xe1;squez Eduardo, Alarc&#xf3;n Graciela S, Pastor-Asurza CA, Alfaro-Lozano JL, Cucho-Venegas JM, Segami MI, Wojdyla D, Soriano ER, Drenkard C, Brenol JC, de Oliveira e Silva Montandon AC, Costallat LTL, Massardo L, Molina-Restrepo JF, Guibert-Toledano M, Silveira LH, Amigo MC, Barile-Fabris LA, Chac&#xf3;n-D&#xed;az Rosa, Esteva-Spinetti MH, Pons-Estel GJ, McGwin G, Pons-Estel BA, GLADEL The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort. Ann Rheum Dis. 2015 Jun;74(6):1019&#x2013;23. doi: 10.1136/annrheumdis-2013-204620.annrheumdis-2013-204620</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-204620</ArticleId><ArticleId IdType="pubmed">24525909</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanly JG, O'Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae S, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Fortin P, Gladman DD, Sanchez-Guerrero J, Petri M, Bruce IN, Dooley MA, Ramsey-Goldman R, Aranow C, Alarc&#xf3;n Graciela S, Fessler BJ, Steinsson K, Nived O, Sturfelt GK, Manzi S, Khamashta MA, van Vollenhoven RF, Zoma AA, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Stoll T, Inanc M, Kalunian KC, Kamen DL, Maddison P, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford) 2016 Feb;55(2):252&#x2013;62. doi: 10.1093/rheumatology/kev311. 
 
kev311</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kev311</ArticleId><ArticleId IdType="pmc">PMC4939728</ArticleId><ArticleId IdType="pubmed">26342222</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan A, Amelio J, Gairy K, Kaur G, Levy RA, Roth D, Bass D. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. Lupus. 2020 Aug;29(9):1011&#x2013;1020. doi: 10.1177/0961203320932219. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320932219?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1177/0961203320932219</ArticleId><ArticleId IdType="pmc">PMC7425376</ArticleId><ArticleId IdType="pubmed">32571142</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena R, Mahajan T, Mohan C. Lupus nephritis: current update. Arthritis Res Ther. 2011;13(5):240. doi: 10.1186/ar3378. 
 
ar3378</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3378</ArticleId><ArticleId IdType="doi">10.1186/ar3378</ArticleId><ArticleId IdType="pmc">PMC3308062</ArticleId><ArticleId IdType="pubmed">22078716</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanouriakis A, Bertsias G, Boumpas DT. Hydroxychloroquine dosing in systemic lupus erythematosus: response to 'Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis by Costedoat-Chalumeau. Ann Rheum Dis. 2020 Aug;79(8):e91. doi: 10.1136/annrheumdis-2019-215615.annrheumdis-2019-215615</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215615</ArticleId><ArticleId IdType="pubmed">31201171</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight CL, Nelson-Piercy C. Management of systemic lupus erythematosus during pregnancy: challenges and solutions. Open Access Rheumatol. 2017;9:37&#x2013;53. doi: 10.2147/OARRR.S87828. 
 
oarrr-9-037</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OARRR.S87828</ArticleId><ArticleId IdType="pmc">PMC5354538</ArticleId><ArticleId IdType="pubmed">28331377</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok CC, Wong RW. Pregnancy in systemic lupus erythematosus. Postgrad Med J. 2001 Mar;77(905):157&#x2013;65. doi: 10.1136/pmj.77.905.157. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pmj.77.905.157</ArticleId><ArticleId IdType="pmc">PMC1741938</ArticleId><ArticleId IdType="pubmed">11222822</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmsten K, Simard JF, Chambers CD, Arkema EV. Medication use among pregnant women with systemic lupus erythematosus and general population comparators. Rheumatology (Oxford) 2017 Apr 01;56(4):561&#x2013;569. doi: 10.1093/rheumatology/kew448. 
 
kew448</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kew448</ArticleId><ArticleId IdType="pmc">PMC5850850</ArticleId><ArticleId IdType="pubmed">28013193</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki C, Sruamsiri R, Mahlich J, Jung W. Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study. J Med Econ. 2020 Jul;23(7):786&#x2013;799. doi: 10.1080/13696998.2020.1740236. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13696998.2020.1740236</ArticleId><ArticleId IdType="doi">10.1080/13696998.2020.1740236</ArticleId><ArticleId IdType="pubmed">32149541</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Zhao Y, Zhang Z, Huang C, Liu Y, Gu J, Zhang Xiao, Xu Huji, Li Xiaofeng, Wu Lijun, Song Yijun, Li Xuemei, Jin Hongzhong, Lei Junqiang, Chen Yaolong, Zeng Xiaofeng, Chinese Rheumatology Association&#x201a; National Clinical Research Center for Dermatologic Immunologic Diseases&#x201a; Chinese Systemic Lupus Erythematosus Treatment Research Group  2020 Chinese Guidelines for the Diagnosis and Treatment of Systemic Lupus Erythematosus. Rheumatol Immunol Res. 2020 Dec;1(1):5&#x2013;23. doi: 10.2478/rir-2020-0009. 
 
rir-2020-0009</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/rir-2020-0009</ArticleId><ArticleId IdType="pmc">PMC9524765</ArticleId><ArticleId IdType="pubmed">36465077</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnosis and Treatment Guidelines Writing Group  Chinese guidelines for diagnostic and treatment of lupus nephritis. Natl Med J China. 2019 Nov 26;:3441&#x2013;3455. doi: 10.3760/cma.j.issn.0376-2491.2019.44.001. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.0376-2491.2019.44.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymona-Pa&#x142;kowska K, Janowski K, Pedrycz A, Mucha D, Ambro&#x17c;y T, Siermontowski P, Adamczuk J, Sapalska M, Mucha D, Kraczkowski J. Knowledge of the Disease, Perceived Social Support, and Cognitive Appraisals in Women with Urinary Incontinence. Biomed Res Int. 2016;2016:3694792. doi: 10.1155/2016/3694792. doi: 10.1155/2016/3694792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/3694792</ArticleId><ArticleId IdType="doi">10.1155/2016/3694792</ArticleId><ArticleId IdType="pmc">PMC5209598</ArticleId><ArticleId IdType="pubmed">28097132</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Luan W, Geng S, Ye S, Wang X, Qian L, Ding Y, Li T, Jiang A. Lack of patient education is risk factor of disease flare in patients with systemic lupus erythematosus in China. BMC Health Serv Res. 2019 Jun 13;19(1):378. doi: 10.1186/s12913-019-4206-y. 
 
10.1186/s12913-019-4206-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-019-4206-y</ArticleId><ArticleId IdType="doi">10.1186/s12913-019-4206-y</ArticleId><ArticleId IdType="pmc">PMC6567412</ArticleId><ArticleId IdType="pubmed">31196083</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutcliffe N, Clarke A E, Gordon C, Farewell V, Isenberg D A. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford) 1999 Nov;38(11):1130&#x2013;7. doi: 10.1093/rheumatology/38.11.1130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/38.11.1130</ArticleId><ArticleId IdType="pubmed">10556268</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J, Sklar GE, Min Sen Oh Vernon, Chuen Li Shu. Factors affecting therapeutic compliance: A review from the patient's perspective. Ther Clin Risk Manag. 2008 Feb;4(1):269&#x2013;86. doi: 10.2147/tcrm.s1458. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/tcrm.s1458</ArticleId><ArticleId IdType="pmc">PMC2503662</ArticleId><ArticleId IdType="pubmed">18728716</ArticleId></ArticleIdList></Reference><Reference><Citation>Chehab G, Sauer GM, Richter JG, Brinks R, Willers R, Fischer-Betz R, Winkler-Rohlfing B, Schneider M. Medical adherence in patients with systemic lupus erythematosus in Germany: predictors and reasons for non-adherence - a cross-sectional analysis of the LuLa-cohort. Lupus. 2018 Sep;27(10):1652&#x2013;1660. doi: 10.1177/0961203318785245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203318785245</ArticleId><ArticleId IdType="pubmed">30020020</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B, Feng G, Tang W, Huang X, Yan H, He Y, Chen W, Da Z, Liu H, Gu Z. The quality of life in Chinese patients with systemic lupus erythematosus is associated with disease activity and psychiatric disorders: a path analysis. Clin Exp Rheumatol. 2014;32(1):101&#x2013;7.7185</Citation><ArticleIdList><ArticleId IdType="pubmed">24029416</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh SV, Nagaraja HN, Hebert L, Rovin BH. Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis. Clin J Am Soc Nephrol. 2014 Feb;9(2):279&#x2013;84. doi: 10.2215/CJN.05040513. 
 
CJN.05040513</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05040513</ArticleId><ArticleId IdType="pmc">PMC3913239</ArticleId><ArticleId IdType="pubmed">24262502</ArticleId></ArticleIdList></Reference><Reference><Citation>Pope Janet E. Measuring flares in systemic lupus erythematosus. Rheumatology (Oxford) 2014 Dec;53(12):2134&#x2013;5. doi: 10.1093/rheumatology/keu274.keu274</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu274</ArticleId><ArticleId IdType="pubmed">25065015</ArticleId></ArticleIdList></Reference><Reference><Citation>Brant R. Assessing proportionality in the proportional odds model for ordinal logistic regression. Biometrics. 1990 Dec;46(4):1171&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">2085632</ArticleId></ArticleIdList></Reference><Reference><Citation>Urba&#x144;ski M. Comparing Push and Pull Factors Affecting Migration. Economies. 2022 Jan 10;10(1):21. doi: 10.3390/economies10010021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/economies10010021</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri MA, van Vollenhoven RF, Buyon J, Levy RA, Navarra SV, Cervera R, Zhong ZJ, Freimuth WW, BLISS-52BLISS-76 Study Groups  Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials. Arthritis Rheum. 2013 Aug;65(8):2143&#x2013;53. doi: 10.1002/art.37995. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.37995</ArticleId><ArticleId IdType="doi">10.1002/art.37995</ArticleId><ArticleId IdType="pubmed">23754628</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajji M, Harzallah A, Kaaroud H, Barbouch S, Hamida FB, Abdallah TB. Factors associated with relapse of lupus nephritis: A single center study of 249 cases. Saudi J Kidney Dis Transpl. 2017;28(6):1349&#x2013;1355. doi: 10.4103/1319-2442.220863. 
 
SaudiJKidneyDisTranspl_2017_28_6_1349_220863</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1319-2442.220863</ArticleId><ArticleId IdType="pubmed">29265046</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng X, Zheng L, Rui H, Kang R, Chen J, Chen H, Liu J. Risk factors for the flare of systemic lupus erythematosus and its influence on prognosis: a single-center retrospective analysis. Adv Rheumatol. 2021 Jul 02;61(1):43. doi: 10.1186/s42358-021-00202-7.10.1186/s42358-021-00202-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42358-021-00202-7</ArticleId><ArticleId IdType="pubmed">34215349</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning S, Duan S, Wenning R. The Forecast of the Number of Outpatients and Discharged Patients in the Twelfth Five-year Plan Period. Chinese Medical Record. 2011:48&#x2013;50. doi: 10.3969/j.issn.1672-2566.2011.10.029. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1672-2566.2011.10.029</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou GJ, Jiang XB, Yuan D, Luo JF, Sun H. Seasonal variation trend analysis on outpatient visits in a dermatology hospital from 2013 to 2017. Shanghai Journal of Preventive Medicine. 2019:70&#x2013;73. doi: 10.19428/j.cnki.sjpm.2019.18892. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.19428/j.cnki.sjpm.2019.18892</ArticleId></ArticleIdList></Reference><Reference><Citation>McDermott EM, Powell RJ. Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide. Ann Rheum Dis. 1996 Apr;55(4):224&#x2013;9. doi: 10.1136/ard.55.4.224. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.55.4.224</ArticleId><ArticleId IdType="pmc">PMC1010142</ArticleId><ArticleId IdType="pubmed">8733438</ArticleId></ArticleIdList></Reference><Reference><Citation>Konttinen YT, Santavirta N, Honkanen V, Sandelin S, Schauman L, Gr&#xf6;nblad M. Systemic lupus erythematosus patient guide: influence on knowledge of the disease. Ann Rheum Dis. 1991 Dec;50(12):900&#x2013;2. doi: 10.1136/ard.50.12.900. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.50.12.900</ArticleId><ArticleId IdType="pmc">PMC1004577</ArticleId><ArticleId IdType="pubmed">1768155</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsou M. Association of Education, Health Behaviors, Concerns, and Knowledge with Metabolic Syndrome among Urban Elderly in One Medical Center in Taiwan. International Journal of Gerontology. 2017 Sep;11(3):138&#x2013;143. doi: 10.1016/j.ijge.2016.09.006. doi: 10.1016/j.ijge.2016.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijge.2016.09.006</ArticleId><ArticleId IdType="doi">10.1016/j.ijge.2016.09.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen R, Newman JF. Societal and Individual Determinants of Medical Care Utilization in the United States. &#xa0;Milbank Q. 2005;83:1&#x2013;28. doi: 10.1111/j.1468-0009.2005.00428.x. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-0009.2005.00428.x</ArticleId><ArticleId IdType="pubmed">4198894</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghupathi V, Raghupathi W. The influence of education on health: an empirical assessment of OECD countries for the period 1995-2015. Arch Public Health. 2020;78:20. doi: 10.1186/s13690-020-00402-5. 
 
402</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13690-020-00402-5</ArticleId><ArticleId IdType="doi">10.1186/s13690-020-00402-5</ArticleId><ArticleId IdType="pmc">PMC7133023</ArticleId><ArticleId IdType="pubmed">32280462</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Alper HE, Nguyen A, Brackbill RM, Turner L, Walker DJ, Maslow CB, Zweig KC. The effectiveness of a monetary incentive offer on survey response rates and response completeness in a longitudinal study. BMC Med Res Methodol. 2017 Apr 26;17(1):77. doi: 10.1186/s12874-017-0353-1. 
 
10.1186/s12874-017-0353-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-017-0353-1</ArticleId><ArticleId IdType="doi">10.1186/s12874-017-0353-1</ArticleId><ArticleId IdType="pmc">PMC5406995</ArticleId><ArticleId IdType="pubmed">28446131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis EM, Klein WM, Orehek E, Ferrer RA. Effects of Emotion on Medical Decisions Involving Tradeoffs. Med Decis Making. 2018 Oct 20;38(8):1027&#x2013;1039. doi: 10.1177/0272989x18806493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0272989x18806493</ArticleId><ArticleId IdType="pmc">PMC6262828</ArticleId><ArticleId IdType="pubmed">30343624</ArticleId></ArticleIdList></Reference><Reference><Citation>Gengler AM. Emotions and Medical Decision-Making. Soc Psychol Q. 2020 Apr 16;83(2):174&#x2013;194. doi: 10.1177/0190272519876937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0190272519876937</ArticleId></ArticleIdList></Reference><Reference><Citation>Yukalov VI. Quantification of emotions in decision making. Soft Comput. 2021 Nov 05;26(5):2419&#x2013;2436. doi: 10.1007/s00500-021-06442-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00500-021-06442-5</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>